Biddle Warner Weston 4
4 · Kyverna Therapeutics, Inc. · Filed Apr 15, 2025
Insider Transaction Report
Form 4
Biddle Warner Weston
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2024-04-11+332,500→ 332,500 totalExercise: $2.06Exp: 2035-04-11→ Common Stock (332,500 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on April 11, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.